Search Results - "Land, R."

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS by WAPNIR, Irene L, DIGNAM, James J, WOLMARK, Norman, FISHER, Bernard, MAMOUNAS, Eleftherios P, ANDERSON, Stewart J, JULIAN, Thomas B, LAND, Stephanie R, MARGOLESE, Richard G, SWAIN, Sandra M, COSTANTINO, Joseph P

“…Ipsilateral breast tumor recurrence (IBTR) is the most common failure event after lumpectomy for ductal carcinoma in situ (DCIS). We evaluated invasive IBTR…”
Get full text

The impact of clozapine on hospital use: a systematic review and meta‐analysis by Land, R., Siskind, D., McArdle, P., Kisely, S., Winckel, K., Hollingworth, S. A.

“…Objective The objective of this study was to perform a systematic review and meta‐analysis of studies reporting the impact of clozapine on hospital use in…”
Get full text

The appropriation and repurposing of social technologies in higher education by Hemmi, A., Bayne, S., Land, R.

“…This paper presents some of the findings from a recent project that conducted a virtual ethnographic study of three formal courses in higher education that use…”
Get full text

Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24 by CRAIG ALLRED, D, ANDERSON, Stewart J, LAND, Stephanie R, WOLMARK, Norman, PAIK, Soonmyung, LAWRENCE WICKERHAM, D, NAGTEGAAL, Iris D, SWAIN, Sandra M, MAMOUNAS, Elefetherios P, JULIAN, Thomas B, GEYER, Charles E, COSTANTINO, Joseph P

“…The NSABP (National Surgical Adjuvant Breast and Bowel Project) B-24 study demonstrated significant benefit with adjuvant tamoxifen in patients with ductal…”
Get full text

Increasing Systemic Immune-Inflammation Index During Treatment in Patients with Advanced Pancreatic Cancer is Associated with Poor Survival – A Retrospective, Multicenter, Cohort Study by Van ‘t Land, Freek R., Aziz, Mohammad H., Michiels, Nynke, Mieog, J. Sven D., Bonsing, Bert A., Luelmo, Saskia A.C., Homs, Marjolein Y.V., Groot Koerkamp, Bas, Papageorgiou, Grigorios, van Eijck, Casper H.J.

“…A high systemic immune-inflammation index (SIII) at diagnosis of various cancers, including pancreatic cancer, is associated with poor prognosis. The impact of…”
Get full text

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection by Ashikaga, Takamaru, Krag, David N., Land, Stephanie R., Julian, Thomas B., Anderson, Stewart J., Brown, Ann M., Skelly, Joan M., Harlow, Seth P., Weaver, Donald L., Mamounas, Eleftherios P., Costantino, Joseph P., Wolmark, Norman

“…Background and Objectives Three year post‐surgical morbidity levels were compared between patients with negative sentinel lymph node dissection alone (SLND)…”
Get full text

Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer by Swain, Sandra M, Jeong, Jong-Hyeon, Geyer, Charles E, Costantino, Joseph P, Pajon, Eduardo R, Fehrenbacher, Louis, Atkins, James N, Polikoff, Jonathan, Vogel, Victor G, Erban, John K, Rastogi, Priya, Livingston, Robert B, Perez, Edith A, Mamounas, Eleftherios P, Land, Stephanie R, Ganz, Patricia A, Wolmark, Norman

“…In node-positive breast cancer, adjuvant doxorubicin plus cyclophosphamide followed by docetaxel was associated with significantly better disease-free survival…”
Get full text

Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer by van 't Land, Freek R, Willemsen, Marcella, Bezemer, Koen, van der Burg, Sjoerd H, van den Bosch, Thierry P P, Doukas, Michail, Fellah, Amine, Kolijn, P Martijn, Langerak, Anton W, Moskie, Miranda, van der Oost, Elise, Rozendaal, Nina E M, Baart, Sara J, Aerts, Joachim G J V, van Eijck, Casper H J

“…Immunotherapies have shown limited responses in patients with advanced pancreatic cancer. Recently, we reported that dendritic cell (DC)-based immunotherapy…”
Get full text

Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia by FOON, Kenneth A, BOYIADZIS, Michael, SCHAEFER, Patricia, LENZER, Diana, TARHINI, Ahmad, LAND, Stephanie R, MARKS, Stanley, RAPTIS, Anastasios, PIETRAGALLO, Louis, MEISNER, Dennis, LAMAN, Andrew, SULECKI, Mathew, BUTCHKO, Allyson

“…Chemoimmunotherapy combining fludarabine, cyclophosphamide, and rituximab (FCR) is an active regimen for untreated patients with chronic lymphocytic leukemia…”
Get full text

Long‐term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C‐07 and LTS‐01 by Kidwell, Kelley M., Yothers, Greg, Ganz, Patricia A., Land, Stephanie R., Ko, Clifford Y., Cecchini, Reena S., Kopec, Jacek A., Wolmark, Norman

“…BACKGROUND: Neurotoxicity from adjuvant treatment with oxaliplatin has been studied in patients with colorectal carcinoma in short‐term studies, but, to the…”
Get full text

Quality of life of locally advanced pancreatic cancer patients after FOLFIRINOX treatment by van der Sijde, Fleur, Schafthuizen, Laura, van ’t Land, Freek R., Moskie, Miranda, van Laarhoven, Hanneke W. M., van Dijk, Monique, van Eijck, Casper H. J.

“…  Background Quality of life in cancer patients might be affected by chemotherapy-induced toxicity. Especially in patients with pancreatic ductal…”
Get full text

Patient-Reported Outcomes in Sentinel Node–Negative Adjuvant Breast Cancer Patients Receiving Sentinel-Node Biopsy or Axillary Dissection: National Surgical Adjuvant Breast and Bowel Project Phase III Protocol B-32 by LAND, Stephanie R, KOPEC, Jacek A, JULIAN, Thomas B, BROWN, Ann M, ANDERSON, Stewart J, KRAG, David N, CHRISTIAN, Nicholas J, COSTANTINO, Joseph P, WOLMARK, Norman, GANZ, Patricia A

“…Sentinel lymph node resection (SNR) may reduce morbidity while providing the same clinical utility as conventional axillary dissection (AD). National Surgical…”
Get full text

Neoadjuvant Treatment of Regional Stage IIIB Melanoma With High-Dose Interferon Alfa-2b Induces Objective Tumor Regression in Association With Modulation of Tumor Infiltrating Host Cellular Immune Responses by MOSCHOS, Stergios J, EDINGTON, Howard D, LAND, Stephanie R, RAO, Uma N, JUKIC, Drazen, SHIPE-SPOTLOE, Janice, KIRKWOOD, John M

“…Adjuvant high-dose interferon-alfa-2b (HDI) improves disease-free and overall survival in patients with high-risk melanoma. However, its mechanism of action is…”
Get full text

Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX – The LAPC-2 trial by van 't Land, Freek R., Latifi, Diba, Moskie, Miranda, Homs, Marjolein Y.V., Bosscha, Koop, Bonsing, Bert A., Mieog, Sven D., van der Harst, Erwin, Coene, Peter-Paul L.O., Wijsman, Jan H., van der Schelling, George P., Groot Koerkamp, Bas, Nuyttens, Joost J., van Eijck, Casper H.J.

“…•The combination treatment of stereotactic body radiotherapy (SBRT) and IMM-101 is safe and feasible for locally advanced pancreatic cancer patients.•Clinical…”
Get full text

A comparison of tobacco product prevalence by different frequency of use thresholds across three US surveys by Sánchez-Romero, Luz María, Cadham, Christopher J, Hirschtick, Jana L, Mattingly, Delvon T, Cho, Beomyoung, Fleischer, Nancy L, Brouwer, Andrew, Mistry, Ritesh, Land, Stephanie R, Jeon, Jihyoun, Meza, Rafael, Levy, David T

“…With the increasing changes in tobacco use patterns, "current use" definition and the survey used may have important implications for monitoring population use…”
Get full text

Cigarette Smoking, Physical Activity, and Alcohol Consumption as Predictors of Cancer Incidence among Women at High Risk of Breast Cancer in the NSABP P-1 Trial by LAND, Stephanie R, QING LIU, WICKERHAM, D. Lawrence, COSTANTINO, Joseph P, GANZ, Patricia A

“…NSABP P-1 provides an opportunity to examine the association of behavioral factors with prospectively monitored cancer incidence and interactions with…”
Get full text

Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial by MAMOUNAS, Eleftherios P, JEONG, Jong-Hyeon, PAJON, Eduardo R, VOGEL, Victor G, KROENER, Joan F, HUTCHINS, Laura F, ROBIDOUX, André, HOEHN, James L, INGLE, James N, GEYER, Charles E, COSTANTINO, Joseph P, WOLMARK, Norman, WICKERHAM, D. Lawrence, SMITH, Roy E, GANZ, Patricia A, LAND, Stephanie R, EISEN, Andrea, FEHRENBACHER, Louis, FARRAR, William B, ATKINS, James N

“…Patients with early-stage, hormone receptor-positive breast cancer have considerable residual risk for recurrence after completing 5 years of adjuvant…”
Get full text

Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer by van ‘t Land, Freek R, Lau, Sai P, de Koning, Willem, Klaase, Larissa, Vink, Madelief, van Krimpen, Anneloes, Dumas, Jasper, Vadgama, Disha, Nuyttens, Joost J, Mustafa, Dana A. M, Stadhouders, Ralph, Willemsen, Marcella, Stubbs, Andrew P, Aerts, Joachim G, van Eijck, Casper H. J

“…Background: Patients with locally advanced pancreatic cancer (LAPC) are treated with chemotherapy. In selected cases, stereotactic body radiotherapy (SBRT) can…”
Get full text

Pancreatectomy with arterial resection for periampullary cancer: outcomes after planned or unplanned events in a nationwide, multicentre cohort by Stoop, Thomas F, Mackay, Tara M, Brada, Lilly J H, van der Harst, Erwin, Daams, Freek, Land, Freek R van ‘t, Kazemier, Geert, Patijn, Gijs A, van Santvoort, Hjalmar C, de Hingh, Ignace H, Bosscha, Koop, Seelen, Leonard W F, Nijkamp, Maarten W, Stommel, Martijn W J, Liem, Mike S L, Busch, Olivier R, Coene, Peter-Paul L O, van Dam, Ronald M, de Wilde, Roeland F, Mieog, J Sven D, Quintus Molenaar, I, Besselink, Marc G, van Eijck, Casper H J

Get full text

Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial) by Lau, Sai Ping, van ’t Land, Freek R, van der Burg, Sjoerd H, Homs, Marjolein Y V, Lolkema, Martijn P, Aerts, Joachim G J V, van Eijck, Casper H J

“…IntroductionThe prognosis of patients with advanced pancreatic ductal adenocarcinoma (PDAC) is dismal and conventional chemotherapy treatment delivers limited…”
Get full text